Artwork

Content provided by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

DED Research Roundup

1:07:53
 
Share
 

Manage episode 476986517 series 2352501
Content provided by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Welcome to "Try Not 2 Blink," where cutting-edge research meets practical clinical insights! In today's episode, Roya and Sheila delve into a compelling headline: "Scleral lenses are effective and ‘safe overall’ for pediatric patients." They will dissect a groundbreaking retrospective study, exploring key findings such as the alarming fact that ocular surface disease accounted for 70% of cases, and why clinicians should be proactive in referring young patients for scleral lens assessments.
We are privileged to welcome Dr. Sathi Maiti, a prominent figure in dry eye research, who has been instrumental in many recent pivotal studies. Dr. Maiti will share her expertise on Xdemvy, the innovative treatment for Demodex blepharitis, and provide best practices for its application in clinical settings.
Additionally, we’ll tackle the ongoing debate surrounding Meibo—whether it’s classified as a lubricating drop or a drug—and review the latest advancements in in-office dry eye treatments. We’ll also address how to identify and manage ocular pain disorders, including neuropathic and neurotrophic pain.
This is an episode you won't want to miss!
Do you have a specific topic you’re passionate about? Or perhaps an expert or prominent figure you’d like us to feature on our podcast? We invite you to share your suggestions and help shape our future content!
Don’t hesitate to reach out to us at [email protected]

SOURCES

Scleral Lenses are Safe for Kids

21 Year Retrospective Review: Kids + Scleral Lenses

Tooth + Cornea Transplant

Dr. Sathi Maiti: LinkedIn

Dr. Sathi Maiti: Periman Eye Institute

Dr. Sathi Maiti: Eye Eye

Dr. Sathi Maiti: Instagram

Dr. Maiti in Eyes on Eyecare

IPL for DIOSD

CIC clinical investigator AAO

2020 on sight

Try Not to Blink Podcast is powered by Valley Contax

  continue reading

332 episodes

Artwork

DED Research Roundup

Try Not To Blink

21 subscribers

published

iconShare
 
Manage episode 476986517 series 2352501
Content provided by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Welcome to "Try Not 2 Blink," where cutting-edge research meets practical clinical insights! In today's episode, Roya and Sheila delve into a compelling headline: "Scleral lenses are effective and ‘safe overall’ for pediatric patients." They will dissect a groundbreaking retrospective study, exploring key findings such as the alarming fact that ocular surface disease accounted for 70% of cases, and why clinicians should be proactive in referring young patients for scleral lens assessments.
We are privileged to welcome Dr. Sathi Maiti, a prominent figure in dry eye research, who has been instrumental in many recent pivotal studies. Dr. Maiti will share her expertise on Xdemvy, the innovative treatment for Demodex blepharitis, and provide best practices for its application in clinical settings.
Additionally, we’ll tackle the ongoing debate surrounding Meibo—whether it’s classified as a lubricating drop or a drug—and review the latest advancements in in-office dry eye treatments. We’ll also address how to identify and manage ocular pain disorders, including neuropathic and neurotrophic pain.
This is an episode you won't want to miss!
Do you have a specific topic you’re passionate about? Or perhaps an expert or prominent figure you’d like us to feature on our podcast? We invite you to share your suggestions and help shape our future content!
Don’t hesitate to reach out to us at [email protected]

SOURCES

Scleral Lenses are Safe for Kids

21 Year Retrospective Review: Kids + Scleral Lenses

Tooth + Cornea Transplant

Dr. Sathi Maiti: LinkedIn

Dr. Sathi Maiti: Periman Eye Institute

Dr. Sathi Maiti: Eye Eye

Dr. Sathi Maiti: Instagram

Dr. Maiti in Eyes on Eyecare

IPL for DIOSD

CIC clinical investigator AAO

2020 on sight

Try Not to Blink Podcast is powered by Valley Contax

  continue reading

332 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play